MiNK Therapeutics, Inc.·4

Mar 5, 6:00 PM ET

WIINBERG ULF 4

4 · MiNK Therapeutics, Inc. · Filed Mar 5, 2024

Insider Transaction Report

Form 4
Period: 2024-03-01
WIINBERG ULF
Director
Transactions
  • Award

    Common Stock

    2024-03-01$0.95/sh+15,790$15,00190,333 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    278,300
Footnotes (2)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
  • [F2]Shares are held in an irrevocable trust for the benefit of Mr. Wiinberg's family.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4